Cannabix Technologies Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Ravinder S. Mlait
- Full Time Employees
- 4,900
- Sector
- Basic Materials
- Industry
- Other Precious Metals
- Address
- 501 - 3292 Production Way Burnaby BC Canada V5A 4R4
- IPO Date
- Aug 27, 2014
- Website
- cannabixtechnologies.com
- Similar Companies
- Business
- Cannabix Technologies Inc. develops marijuana breathalyzer and alcohol screening technologies for law enforcement, workplaces, employers, and laboratories primarily in North America. The company offers the Cannabix Marijuana Breathalyzer (CMB) system, comprising the Breath Collection Unit (BCU) for sample capture in proprietary cartridges and the MS Breath Sampler (MSBS) hardware for laboratory analysis of delta-9 THC via mass spectrometry; BreathLogix wall-mounted, contactless alcohol breathalyzer devices with cloud connectivity, photo capture, and real-time BAC reporting for employee access control; and field asymmetric ion mobility spectrometry (FAIMS) technology for portable THC detection. Cannabix Technologies maintains operations in Canada and the United States, with pilot testing in Australia, South Africa, and Texas; the company was incorporated in 2011 and is headquartered in Burnaby, British Columbia. In May 2024, Cannabix entered a strategic partnership and development agreement with Omega Laboratories, granting Omega exclusive North American rights to process CMB breath cartridges for five years, advancing validation, commercialization, and potential manufacturing/distribution while issuing 1,000,000 common shares and up to 11,000,000 special warrants tied to milestones. The company commenced initial commercial production of BreathLogix components with contract manufacturer Price Electronics in July 2025 and secured an exclusive distribution agreement with Breathalyser Sales & Service Pty Ltd. for Australia, New Zealand, and Pacific Islands. Recent developments include appointment of Omega Laboratories CEO William R. Corl to the board, a notice of allowance for its contact-free breath analysis patent from the Canadian Intellectual Property Office, repeat orders for BreathLogix devices, and participation in the NSC Safety Congress & Expo.
Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
Cannabix Technologies Announces Detection of Methamphetamine and Amphetamine in Human Breath
Cannabix Technologies Announces First BreathLogix Alcohol Device Deployment to West Africa for Mining Sector
Cannabix Technologies Announces Deployment of Marijuana Breath Test (MBT) with Major Industrial Operator in Quebec
Cannabix Expands BreathLogix Alcohol Screening Technology into Mining, Municipal and Aviation Sectors in Australia
Cannabix Marijuana Breath Test Achieves Major Milestone: Breath Collection Unit Secures UL and CSA Certifications
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Workplace Drug and Alcohol Testing Clinic
Omega Laboratories to Host Educational Panels and Present Cannabix Marijuana Breath Test Solution at the 2026 NDASA Conference in California
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT)
Journal of Analytical Toxicology Publishes Peer‑Reviewed Validation Study Demonstrating Accuracy of Omega Laboratories' Test Method for Detecting Marijuana in Breath Samples Using Cannabix Technologies' Breath Collection Unit
Cannabix Technologies Closes Non-Brokered Private Placement
Cannabix Technologies (OTCMKTS:BLOZF) Stock Price Down 3.6% – Time to Sell?
Cannabix Technologies announces Non-Brokered LIFE Private Placement
Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro's 2026 Product Catalog
Cannabix Technologies (OTCMKTS:BLOZF) Trading 0.1% Higher – Should You Buy?
Short Interest in Cannabix Technologies Inc. (OTCMKTS:BLOZF) Increases By 105.8%
Cannabix Technologies Launches New Marijuana Breath Test Product Videos as U.S. Cannabis Reclassification Underscores the Urgent Need for Innovative Public Safety Solutions